These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 29749488)
21. [Effect of glucocorticoid on the expression of Puma in acute lymphoblastic leukemia]. Xu B; Wang BJ; Li AM; Lock R Zhongguo Dang Dai Er Ke Za Zhi; 2006 Apr; 8(2):151-4. PubMed ID: 16613713 [TBL] [Abstract][Full Text] [Related]
22. Clinical significance of high c-MYC and low MYCBP2 expression and their association with Ikaros dysfunction in adult acute lymphoblastic leukemia. Ge Z; Guo X; Li J; Hartman M; Kawasawa YI; Dovat S; Song C Oncotarget; 2015 Dec; 6(39):42300-11. PubMed ID: 26517351 [TBL] [Abstract][Full Text] [Related]
23. MiR-124 contributes to glucocorticoid resistance in acute lymphoblastic leukemia by promoting proliferation, inhibiting apoptosis and targeting the glucocorticoid receptor. Liang YN; Tang YL; Ke ZY; Chen YQ; Luo XQ; Zhang H; Huang LB J Steroid Biochem Mol Biol; 2017 Sep; 172():62-68. PubMed ID: 28578002 [TBL] [Abstract][Full Text] [Related]
24. Glucocorticoids induce G1 as well as S-phase lengthening in normal human stimulated lymphocytes: differential effects on cell cycle regulatory proteins. Baghdassarian N; Catallo R; Mahly MA; Ffrench P; Chizat F; Bryon PA; Ffrench M Exp Cell Res; 1998 May; 240(2):263-73. PubMed ID: 9596999 [TBL] [Abstract][Full Text] [Related]
25. Comparison of the antileukemic activity in vitro of dexamethasone and prednisolone in childhood acute lymphoblastic leukemia. Kaspers GJ; Veerman AJ; Popp-Snijders C; Lomecky M; Van Zantwijk CH; Swinkels LM; Van Wering ER; Pieters R Med Pediatr Oncol; 1996 Aug; 27(2):114-21. PubMed ID: 8649318 [TBL] [Abstract][Full Text] [Related]
26. G1 arrest by p16INK4A uncouples growth from cell cycle progression in leukemia cells with deregulated cyclin E and c-Myc expression. Ausserlechner MJ; Obexer P; Geley S; Kofler R Leukemia; 2005 Jun; 19(6):1051-7. PubMed ID: 15800668 [TBL] [Abstract][Full Text] [Related]
27. Involvement of p27Kip1 in the G1- and S/G2-phase lengthening mediated by glucocorticoids in normal human lymphocytes. Baghdassarian N; Peiretti A; Devaux E; Bryon PA; Ffrench M Cell Growth Differ; 1999 Jun; 10(6):405-12. PubMed ID: 10392902 [TBL] [Abstract][Full Text] [Related]
28. MiR-503 Contributes to Glucocorticoid Sensitivity in Acute Lymphoblastic Leukaemia via Targeting WNT3A. Tian C; Liu L; Zheng M; Ye Z; Chen R; Lan X Folia Biol (Praha); 2021; 67(5-6):199-207. PubMed ID: 35439853 [TBL] [Abstract][Full Text] [Related]
30. Deregulation of FGFR1 and CDK6 oncogenic pathways in acute lymphoblastic leukaemia harbouring epigenetic modifications of the MIR9 family. Rodriguez-Otero P; Román-Gómez J; Vilas-Zornoza A; José-Eneriz ES; Martín-Palanco V; Rifón J; Torres A; Calasanz MJ; Agirre X; Prosper F Br J Haematol; 2011 Oct; 155(1):73-83. PubMed ID: 21810092 [TBL] [Abstract][Full Text] [Related]
31. Tetramethylpyrazine inhibits the proliferation of acute lymphocytic leukemia cell lines via decrease in GSK-3β. Wang XJ; Xu YH; Yang GC; Chen HX; Zhang P Oncol Rep; 2015 May; 33(5):2368-74. PubMed ID: 25812605 [TBL] [Abstract][Full Text] [Related]
32. [P38 mitogen-activated protein kinase mediates glucocorticoid receptor function induced by dexamethasone in acute lymphoblastic leukemia cells]. He L; Li D; Hou KZ; Liu YP Zhonghua Er Ke Za Zhi; 2007 Sep; 45(9):687-91. PubMed ID: 18021564 [TBL] [Abstract][Full Text] [Related]
33. Arsenic trioxide sensitizes glioblastoma to a myc inhibitor. Yoshimura Y; Shiino A; Muraki K; Fukami T; Yamada S; Satow T; Fukuda M; Saiki M; Hojo M; Miyamoto S; Onishi N; Saya H; Inubushi T; Nozaki K; Tanigaki K PLoS One; 2015; 10(6):e0128288. PubMed ID: 26038891 [TBL] [Abstract][Full Text] [Related]
34. Sequential gene regulatory events leading to glucocorticoid-evoked apoptosis of CEM human leukemic cells:interactions of MAPK, MYC and glucocorticoid pathways. Webb MS; Miller AL; Howard TL; Johnson BH; Chumakov S; Fofanov Y; Nguyen-Vu T; Lin CY; Thompson EB Mol Cell Endocrinol; 2018 Aug; 471():118-130. PubMed ID: 29596968 [TBL] [Abstract][Full Text] [Related]
35. Changes in c-myc expression and the kinetics of dexamethasone-induced programmed cell death (apoptosis) in human lymphoid leukaemia cells. Wood AC; Waters CM; Garner A; Hickman JA Br J Cancer; 1994 Apr; 69(4):663-9. PubMed ID: 8142255 [TBL] [Abstract][Full Text] [Related]
36. The pyrrolo-1,5-benzoxazepine, PBOX-15, enhances TRAIL‑induced apoptosis by upregulation of DR5 and downregulation of core cell survival proteins in acute lymphoblastic leukaemia cells. Nathwani SM; Greene LM; Butini S; Campiani G; Williams DC; Samali A; Szegezdi E; Zisterer DM Int J Oncol; 2016 Jul; 49(1):74-88. PubMed ID: 27176505 [TBL] [Abstract][Full Text] [Related]
37. 2-Methoxyestradiol blocks cell-cycle progression at the G2/M phase and induces apoptosis in human acute T lymphoblastic leukemia CEM cells. Zhang X; Huang H; Xu Z; Zhan R Acta Biochim Biophys Sin (Shanghai); 2010 Sep; 42(9):615-22. PubMed ID: 20732853 [TBL] [Abstract][Full Text] [Related]
38. Dexamethasone-induced apoptosis in acute lymphoblastic leukemia involves differential regulation of Bcl-2 family members. Laane E; Panaretakis T; Pokrovskaja K; Buentke E; Corcoran M; Söderhäll S; Heyman M; Mazur J; Zhivotovsky B; Porwit A; Grandér D Haematologica; 2007 Nov; 92(11):1460-9. PubMed ID: 18024393 [TBL] [Abstract][Full Text] [Related]
39. c-Myc and cyclin D3 (CcnD3) genes are independent targets for glucocorticoid inhibition of lymphoid cell proliferation. Rhee K; Bresnahan W; Hirai A; Hirai M; Thompson EA Cancer Res; 1995 Sep; 55(18):4188-95. PubMed ID: 7664296 [TBL] [Abstract][Full Text] [Related]
40. The dual kinase inhibitor NVP-BEZ235 in combination with cytotoxic drugs exerts anti-proliferative activity towards acute lymphoblastic leukemia cells. Schult C; Dahlhaus M; Glass A; Fischer K; Lange S; Freund M; Junghanss C Anticancer Res; 2012 Feb; 32(2):463-74. PubMed ID: 22287733 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]